In OSCC tumour tissues, an overexpression of MGAT5 (also known as GNT-V) enhanced CEACAM6 N-glycosylation, which in turn promoted EGFR signalling that correlated with poor prognosis [15]. This evidence concerns the gene MGAT5 and neoplasm.